Invention description

Identify the core of my invention

Introduction

Identify the core

Stand der Technik

Technische Lösung

Struktur und Form

Fehler vermeiden

Ergebnis

Step

2

of

7

Let's get started

Answer the guiding questions:

What does your solution do differently? Which concrete problem does it solve? Where is the “flash of insight”?
Distinguish from prior work: What was prior work? What is your own contribution? Formulate: “What is essentially new is that …”
Formula: “What is essentially new is that [object/process] now has [new property/capability] by [central measure], thereby [concrete advantage over the state of the art].”

Note your core sentence.

Beispiele

The invention describes a single-use plaster electrode that measures blood glucose non-invasively by impedance spectroscopy in real time and compensates for motion and moisture effects.
The invention describes a self-adjusting bicycle derailleur that automatically aligns chain line and cog play, shortens shift time, and reduces mis-shifts.
The invention describes an ultra-thin, amphiphilic coating that prevents biofouling on stainless steel and can be applied at room temperature.
The invention describes an energy-autonomous window sensor that detects thermal bridges via thermoelectrics and a micro solar film, transmits only at relevant gradients, and operates for years without a battery.
The invention describes a new DNA amplification process that uses a cold-adapted polymerase from the Antarctic bacterium Psychromonas ingrahamii and runs at 20–25 °C, so sensitive samples can be amplified more stably.
The invention describes an inhibitor that acts specifically at miRNA level in tumour cells of triple-negative breast cancer, thereby resensitising chemoresistant tumour cells to standard therapies.
The invention describes an optimised synthesis process for cyclodextrins that uses a recombinant cyclodextrin glycosyltransferase from Bacillus macerans in a continuously operated membrane reactor, thereby increasing yield, avoiding organic solvents, and reducing purification effort for pharmaceutical formulations with poorly soluble active ingredients.

Ready for the next step?

Click here to start step 3 “Outline the state of the art”.

Invention description

Identify the core of my invention

Introduction

Identify the core

Stand der Technik

Technische Lösung

Struktur und Form

Fehler vermeiden

Ergebnis

Step

2

of

7

Let's get started

Answer the guiding questions:

What does your solution do differently? Which concrete problem does it solve? Where is the “flash of insight”?
Distinguish from prior work: What was prior work? What is your own contribution? Formulate: “What is essentially new is that …”
Formula: “What is essentially new is that [object/process] now has [new property/capability] by [central measure], thereby [concrete advantage over the state of the art].”

Note your core sentence.

Beispiele

The invention describes a single-use plaster electrode that measures blood glucose non-invasively by impedance spectroscopy in real time and compensates for motion and moisture effects.
The invention describes a self-adjusting bicycle derailleur that automatically aligns chain line and cog play, shortens shift time, and reduces mis-shifts.
The invention describes an ultra-thin, amphiphilic coating that prevents biofouling on stainless steel and can be applied at room temperature.
The invention describes an energy-autonomous window sensor that detects thermal bridges via thermoelectrics and a micro solar film, transmits only at relevant gradients, and operates for years without a battery.
The invention describes a new DNA amplification process that uses a cold-adapted polymerase from the Antarctic bacterium Psychromonas ingrahamii and runs at 20–25 °C, so sensitive samples can be amplified more stably.
The invention describes an inhibitor that acts specifically at miRNA level in tumour cells of triple-negative breast cancer, thereby resensitising chemoresistant tumour cells to standard therapies.
The invention describes an optimised synthesis process for cyclodextrins that uses a recombinant cyclodextrin glycosyltransferase from Bacillus macerans in a continuously operated membrane reactor, thereby increasing yield, avoiding organic solvents, and reducing purification effort for pharmaceutical formulations with poorly soluble active ingredients.

Ready for the next step?

Click here to start step 3 “Outline the state of the art”.

Invention description

Identify the core of my invention

Introduction

Identify the core

Stand der Technik

Technische Lösung

Struktur und Form

Fehler vermeiden

Ergebnis

Step

2

of

7

Let's get started

Answer the guiding questions:

What does your solution do differently? Which concrete problem does it solve? Where is the “flash of insight”?
Distinguish from prior work: What was prior work? What is your own contribution? Formulate: “What is essentially new is that …”
Formula: “What is essentially new is that [object/process] now has [new property/capability] by [central measure], thereby [concrete advantage over the state of the art].”

Note your core sentence.

Beispiele

The invention describes a single-use plaster electrode that measures blood glucose non-invasively by impedance spectroscopy in real time and compensates for motion and moisture effects.
The invention describes a self-adjusting bicycle derailleur that automatically aligns chain line and cog play, shortens shift time, and reduces mis-shifts.
The invention describes an ultra-thin, amphiphilic coating that prevents biofouling on stainless steel and can be applied at room temperature.
The invention describes an energy-autonomous window sensor that detects thermal bridges via thermoelectrics and a micro solar film, transmits only at relevant gradients, and operates for years without a battery.
The invention describes a new DNA amplification process that uses a cold-adapted polymerase from the Antarctic bacterium Psychromonas ingrahamii and runs at 20–25 °C, so sensitive samples can be amplified more stably.
The invention describes an inhibitor that acts specifically at miRNA level in tumour cells of triple-negative breast cancer, thereby resensitising chemoresistant tumour cells to standard therapies.
The invention describes an optimised synthesis process for cyclodextrins that uses a recombinant cyclodextrin glycosyltransferase from Bacillus macerans in a continuously operated membrane reactor, thereby increasing yield, avoiding organic solvents, and reducing purification effort for pharmaceutical formulations with poorly soluble active ingredients.

Ready for the next step?

Click here to start step 3 “Outline the state of the art”.